The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease
- 31 July 1990
- journal article
- review article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 97 (2-3), 273-293
- https://doi.org/10.1016/0022-510x(90)90225-c
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASEThe Lancet, 1989
- Biochemistry of Parkinson's disease 28 years later: A critical reviewMovement Disorders, 1989
- Dopaminergic mechanisms in hemiparkinsonian monkeysNeurology, 1987
- Chronic treatment withl-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone bindingBrain Research, 1986
- Antioxidants fail to inhibit depletion of striatal dopamine by MPTPNeurology, 1986
- ECOGENETICS OF PARKINSON'S DISEASE: 4-HYDROXYLATION OF DEBRISOQUINEThe Lancet, 1985
- Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in rana pipiensLife Sciences, 1985
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Etiology of Parkinson’s Disease: A Research StrategyCanadian Journal of Neurological Sciences, 1984
- Brain Peroxidase and Catalase in Parkinson DiseaseArchives of Neurology, 1975